Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cohance Lifesciences Limited Call Transcript 2021

Aug 9, 2021

59202_rns_2021-08-09_6688c154-05fd-4de1-9d21-485f5020ccb5.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [118 x 36] intentionally omitted <==

CSD/BSE&NSE/CC/2021-22 August 9, 2021

To To The General Manager The Manager Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: SUVENPHAR

Dear Sir/Madam,

Sub: Schedule of Conference Call for Investors

With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Monday, August 16, 2021 at 10:00 a.m. IST to discuss the Un-audited Financial Results for the Q1FY22 , to be declared on August 13, 2021.

This is for your information and record.

Thanking You, Yours faithfully, For Suven Pharmaceuticals Limited

==> picture [96 x 30] intentionally omitted <==

K Hanumantha Rao Company Secretary

Encl: as above

Suven Pharmaceuticals Limited

Registered Office: # 8-2-334 I SDE Serene Chambers I 3rd Floor I Road No.5 Avenue 7 I Banjara Hills I Hyderabad – 500034 I Telangana I India I CIN: L24299TG2018PLC128171 Tel: 91 40 2354 9414 /1142 /3311 I Fax: 91 40 2354 1152 I Email: [email protected] I www.suvenpharm.com

==> picture [146 x 48] intentionally omitted <==

Suven Pharmaceuticals Ltd to host Q1FY22 Results Conference call on Monday, August 16, 2021 @ 10:00 am IST

Suven Pharmaceuticals Ltd will be conducting a conference call to discuss its Q1FY22 results performance. Suven Pharmaceuticals Ltd will be represented by members of the senior management team.

The conference call will be initiated with a brief discussion after which the floor will be opened for Q&As. The financial results will be announced on August 13, 2021.

In order to pre-register: Copy this URL in your browser :

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4072430&linkSecur ityString=f1b440fc8

Details of the conference call are as follows:

Timing 10:00 am IST on Monday, August 16, 2021
12:30p.m HongKong/ Singapore Time
Conference dial-in
Primarynumber +91 22 6280 1141/+91 22 7115 8042
Singapore Toll Free Number 653 157 5746
HongKongToll Free Number 852 3018 6877
USA Toll Free Number 1 323 386 8721
UK Toll Free Number 44 203 478 5524

- ENDS –

For further information please contact

Venkatraman Sunder, (VP - Corporate Afffairs) Suven Pharmaceuticals Limited Tel: +91 40 2354 9414 Email: [email protected]

Gavin Desa / Rishab Barar CDR India Tel: +91 22 6645 1237/1235 Email: [email protected] [email protected]